Trulieve is a pharmaceutical company that manufactures integrated seed-to-sale medical cannabis products for brain and health treatments.
Trulieve has raised $200.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in December 2025.
Trulieve is headquartered in Quincy, United States.
Trulieve is a pharmaceutical company that manufactures integrated seed-to-sale medical cannabis products for brain and health treatments.
Trulieve is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trulieve — Funding & Investors." VCBacked, December 8, 2025, https://www.vcbacked.co/company/trulieve. Accessed August 13, 2026.
VCBacked. (2025). Trulieve — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/trulieve
{{cite web |title=Trulieve — Funding & Investors |url=https://www.vcbacked.co/company/trulieve |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated